nivolumab,ipilimumab
bms
['improve ']
 has mrd shown to improve overall survival in myeloma ? it is more or less similar situation with pathcr .
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists